Rifabutin
Mycobutin (rifabutin) is a small molecule pharmaceutical. Rifabutin was first approved as Mycobutin on 1992-12-23. It is used to treat mycobacterium avium-intracellulare infection, mycobacterium infections, and pulmonary tuberculosis in the USA.
Trade Name | Mycobutin |
---|---|
Common Name | Rifabutin |
Indication | mycobacterium avium-intracellulare infection, mycobacterium infections, pulmonary tuberculosis |
Drug Class | Antibiotics (rifamycin derivatives) |